Medical News

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Critical Care, Nursing, Hospital, Gi Bleeding, SUP, Acid Suppressive Medications, C Difficile, Clostridium Difficile, Pneumonia, hospital-acquired infection, Proton Pump Inhibitor, EMR

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 1-Jun-2017 6:00 AM EDT

Medicine

Channels:

Ending Platelet Shortage, Emotional Support Animals, Internet Addition, and More in the Children's Health News Source

Click here for the latest research and features on Children's Health.

Medicine

Channels:

Practical Clinical Trials Can Help Find Alternatives to Opioids

Pressures on primary care doctors to move away from opioid pain management are increasing, but practitioners need practical, evidence-based information on how to employ multidisciplinary pain care successfully in everyday clinical practice. A senior investigator for Kaiser Permanente, speaking at the American Pain Society Annual Scientific Conference, believes wider use of practical clinical trials and more emphasis on patient self-management are key solutions for achieving wider use of multidisciplinary pain care to improve patient function and help lower use and misuse of opioids.

Medicine

Channels:

Wearable Devices Communicate Vital Brain Activity Information

What can we learn about emotions, the brain and behavior from a wristband? Plenty, according to a prominent MIT engineer and researcher in her plenary session address at the American Pain Society Annual Scientific Meeting, www.americanpainsociety.org.

Medicine

Channels:

Eye Fluctuations, Current Stimulation, New Gene Therapy, and More in the Vision News Source

The latest research and feature news on vision in the Vision News Source

Medicine

Channels:

Inflammatory Bowel Disease, IBD, Social Media, Social Media and IBD, Social Media and Medication

Researchers Use Social Media to Identify Biggest Concerns Inflammatory Bowel Disease Patients Have with Treatments

Cedars-Sinai researchers analyzed thousands of social media posts to determine the biggest concerns patients with inflammatory bowel disease (IBD) have about their prescribed treatments. The No. 1 patient concern: Risks of side effects from biologic medications even when risks are remote.

Medicine

Channels:

Influenza, Viral, Immunology, BEZ235, St. Jude Children's Research Hospital, Influenza Virus

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-May-2017 12:00 PM EDT

Medicine

Channels:

Nursing Home, UTI, Urinary Tract Infection (UTI), Catheter, Urinary Catheter, Patient Safety, Infection Control

Nursing Homes Cut Urinary Tract Infections in Half Through Focused Effort on Catheter Care

A new study shows a way to keep urinary catheters from posing as much of a risk to the 1.4 million Americans currently in long-term and post-acute care. The research shows that urinary tract infections related to catheters fell by 54 percent in 404 nursing homes in 38 states that took part in a national patient safety effort.

Medicine

Channels:

Dermatology, Sunscreen, Skin Cancer, EWG, American Academy Of Dermatology

American Academy of Dermatology Statement on the Safety of Sunscreen

The American Academy of Dermatology wants to emphasize that sunscreen remains a safe, effective form of sun protection. As one component of a daily sun-protection strategy, sunscreen is an important tool in the fight against skin cancer, including melanoma, the deadliest form of skin cancer.

Medicine

Channels:

biosimilar, biosimilar labeling, biosimilar naming, biosimilars, biosimilar Interchangeability, Rheumatology, FDA, FDA guidance, Food And Drug Administration, Biosimilar User Fee Act II

American College of Rheumatology Responds to FDA Draft Guidance on Biosimilar Interchangeability

Today, the American College of Rheumatology submitted comments to the U.S. Food and Drug Administration concerning the draft guidance, ‘Considerations in Demonstrating Interchangeability with a Reference Product’ (FDA 2017-01042).’







Chat now!